| Product Name |
MF |
CAS |
Details |
| Gliclazide EP Impurity C
Gliclazide BP Impurity C ; Ethyl [(4-methylphenyl)sulfonyl]- carbamate |
C10H13NO4S |
5577-13-9 |
|
| Brexpiprazole Impurity 16
7-(4-Bromobutoxy)-quinoline-2(1H)-one |
C13H14BrNO2 |
203395-59-9 |
|
| Duloxetine Hydrochloride
(S)-N-Methyl-γ-(1-naphthalenyloxy)-2-thiophenepropanamine Hydrochloride |
C18H20ClNOS |
136434-34-9 |
|
| Haloperidol
4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4- fluorophenyl)-1-butanone |
C21H23ClFNO2 |
52-86-8 |
|
| 3-Acetyl-L-tyrosine Methyl Ester Hydrochloride |
C12H15NO4 |
57085-32-2 |
|
| Piroxicam EP Impurity D
Methyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate |
C10H9NO5S |
6639-62-9 |
|
| Phenylephrine EP Impurity E
Phenylephrine Related Compound E ;
2-(benzylmethylamino)-1-(3-hydroxyphenyl)ethanone ; benzylphenylephrone |
C16H17NO2 |
56917-44-3 |
|
| Bumetanide EP Impurity B
Bumetanide Related Compound A ; 3-amino-4-phenoxy-5- sulfamoylbenzoic acid ; Desbutyl Bumetanide |
C13H12N2O5S |
28328-54-3 |
|
| Ivabradine Hydrochloride
(S)-3-(3-(((4,5-dimethoxy-1,2 dihydrocyclobutabenzen1yl)methyl)(methyl)amino)propyl)-7,8- dimethoxy-4,5-dihydro-1Hbenzo[d]azepin-2(3H)-one hydrochloride |
C27H37ClN2O5 |
148849-67-6 |
|
| Ethyl 3-(2-Pyridylamino)propionate |
C10H14N2O2 |
103041-38-9 |
|
| Vildagliptin Chloroacetyl Nitrile (R)-Isomer
Vildagliptin Chloroacetyl Nitrile (R)-Isomer |
C7H9ClN2O |
565452-98-4 |
|
| Meloxicam EP Impurity E
methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide |
C11H11NO5S |
35511-15-0 |
|
| Piroxicam EP Impurity J
Methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3- carboxylate 1,1-dioxide |
C11H11NO5S |
35511-15-0 |
|
| 1-Benzhydrylpiperazine |
C17H20N2 |
841-77-0 |
|
| Pantoprazole
5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2- yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
C16H15F2N3O4S |
102625-70-7 |
|
| Glipizide EP Impurity B
cyclohexanamine |
C6H13N |
108-91-8 |
|
| Albendazole EP Impurity A
5-(Propylthio)-1H-benzimidazol-2-amine |
C10H13N3S |
80983-36-4 |
|
| Piroxicam EP Impurity A
pyridin-2-amine |
C5H6N2 |
504-29-0 |
|
| Paracetamol EP Impurity G
(E)-1-(4-hydroxyphenyl)ethanone oxime |
C8H9NO2 |
198712-64-0 |
|
| Mycophenolate Mofetil EP Impurity E
Mycophenolic Acid Methyl Ester |
C18H22O6 |
31858-66-9 |
|
| Celecoxib Impurity 3
4-(5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1-
yl)benzenesulfonamide |
C16H12F3N3O2S |
170569-87-6 |
|
| 3-(3,4-Dimethoxyphenyl)-L-Alanine |
C11H15NO4 |
32161-30-1 |
|
| Picolonic acid
Pyridine-2-carboxylic Acid |
C6H5NO2 |
98-98-6 |
|
| Losartan Related Compound B
4’-[(2-butyl-4-chloro-5-hydroxymethyl)-1H-imidazol-1-
yl)methyl]-[1,1’-Biphenyl]-2-carbonitrile |
C22H22ClN3O |
114772-55-3 |
|
| Aripiprazole
7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4- dihydroquinolin-2(1H)-one |
C23H27Cl2N3O2 |
129722-12-9 |
|
| Ethacrynic Acid
2-[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid |
C13H12Cl2O4 |
58-54-8 |
|
| Lacosamide EP Impurity A
(S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide |
C13H18N2O3 |
175481-37-5 |
|
| Quetiapine EP Impurity D
Quetiapine Dimer Impurity ; Quetiapine Bis(dibenzothiazepinyl) piperazine Impurity (USP) |
C30H24N4S2 |
945668-94-0 |
|
| Apixaban acid impuity
4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1- piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic
acid |
C25H24N4O5 |
503614-92-4 |
|
| Allopurinol EP Impurity E
Allopurinol USP RC E ; ethyl 5-(formylamino)-1H-pyrazole-4- carboxylate |
C7H9N3O3 |
31055-19-3 |
|
| Olmesartan Medoxomil
(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan- 2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5- yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate |
C29H30N6O6 |
144689-63-4 |
|
| Azilsartan Impurity B
1-((2'-carbamoyl-[1,1'-biphenyl]-4-yl)methyl)
-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid |
C24H21N3O4 |
1696392-11-6 |
|
| Apixaban Impurity 4
ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-
tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
C22H22N4O4 |
503615-07-4 |
|
| Nabumetone EP Impurity A
3-(6-methoxynaphthalen-2-yl)-5-methylcyclohexanone |
C18H20O2 |
343272-52-6 |
|
| Vildagliptin Chloroacetyl Amide (S)-Isomer
(S)-1-(2-chloroacetyl)pyrrolidine-2-carboxamide |
C7H11ClN2O2 |
214398-99-9 |
|
| Bupivacaine EP Impurity D
(2RS)-2,6-Dichloro-N-(2,6-dimethylphenyl)hexanamide |
C14H19Cl2NO |
1037184-07-8 |
|
| Alfuzosin EP Impurity B 2-chloro-6,7-dimethoxyquinazolin-4-amine ; 4-Amino-2-chloro-
6,7-dimethoxyquinazoline ; 2-Chloro-6,7-dimethoxy-4- quinazolinamine |
C10H10ClN3O2 |
23680-84-4 |
|
| Tenteligliptin impurity B
tert-butyl (2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1-
carboxylate |
C27H38N6O3S |
401566-80-1 |
|
| Atenolol EP Impurity F
2,2'-[(1-Methylethyl)iminobis(2-hydroxypropan-3,1diyloxy-4,1- phenylene)]diacetamide |
C25H35N3O6 |
87619-83-8 |
|
| Apremilast Impurity 1
3-Ethoxy-4-methoxy-[(methylsulfonyl)methyl]-(S)- benzenemethanamine |
C12H19NO4S |
608141-42-0 |
|
| Ondansetron EP Impurity G
3-((1H-imidazol-1-yl)methyl)-9-methyl-1,2,3,9-tetrahydro-4H- carbazol-4-one |
C17H17N3O |
99614-03-6 |
|
| 4-Methyl L-Aspartate Hydrochloride
4-Methyl L-Aspartate Hydrochloride |
C5H10ClNO4- |
16856-13-6 |
|
| Amlodipine
3-ethyl 5-Methyl 2-((2-aMinoethoxy)Methyl)-4-(2-chlorophenyl) 6-Methyl-1,4-dihydropyridine-3,5-dicarboxylate Maleate |
C30H35ClN2O12S |
88150-47-4 |
|
| Paracetamol EP Impurity C
N-(3-chloro-4-hydroxyphenyl)acetamide |
C8H8ClNO2 |
3964-54-3 |
|
| 3-Des(allylthio)methyl-3-chloromethyl Althiazide
6-Chloro-3-(chloromethyl)-3,4-dihydro-2H-1,2,4-
benzothiadiazine-7-sulfonamide 1,1-Dioxide |
C8H9Cl2N3O4S2 |
1824-47-1 |
|
| cis-Haloperidol N-Oxide
4-[cis-4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4- fluorophenyl)-1-butanone |
C21H23ClFNO3 |
150214-94-1 |
|
| Alfuzosin EP Impurity E N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)aminopropyl]formamide hydrochloride |
C15H21N5O3 |
1026411-59-5 |
|
| 4-Hyrdroxy Felbamate
2-(4-Hydroxyphenyl)-1,3-propanediyl Dicarbamate |
C11H14N2O5 |
109482-28-2 |
|
| Erythromycin
E-Base; E-Mycin; Erythromycin A |
C37H67NO13 |
114-07-8 |
|
| Mesalazine EP Impurity C
2-aminophenol.; Mesalamine EP Impurity C |
C6H7NO |
95-55-6 |
|
| Mycophenolate Mofetil EP Impurity F
Mycophenolic Acid |
C17H20O6 |
24280-93-1 |
|
| Azilsartan Impurity D
3-((2'-(N'-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl) methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid |
C22H18N4O4 |
1821386-21-3 |
|
| Brexpiprazole N-Oxide
7-[4-(4-Benzo[b]thien-4-yl-1-oxido-1-piperazinyl)butoxy]
-2(1H)-quinolinone |
C25H27N3O3S |
1191900-58-9 |
|
| Glimepiride
1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)
ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea |
C24H34N4O5S |
93479-97-1 |
|
| Lidocaine EP Impurity A
Bupivacaine EP Impurity F ; Lidocaine USP Impurity A ; 2,6- Dimethylaniline |
C8H11N |
87-62-7 |
|
| Labetalol
2-hydroxy-5-((S)-1-hydroxy-2-(((S)-4-phenylbutan-2- yl)amino)ethyl)
benzamide hydrochloride |
C19H25ClN2O3 |
32780-64-6 |
|
| Atomoxetine EP Impurity A
N-methyl-3-phenoxy-3-phenylpropan-1-amine hydrochloride |
C16H20ClNO |
873310-33-9 |
|
| Leflunomide EP Impurity D
5-methylisoxazole-4-carboxylic acid |
C5H5NO3 |
42831-50-5 |
|
| Chlortalidone EP impurity C
Chlorthalidone Acid Ethyl Ester ; 2-[3-(Aminosulfonyl)-4- chlorobenzoyl]-benzonic acid ethyl ester |
C16H14ClNO5S |
92874-73-2 |
|
| Buspirone Hydrochloride
8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]- decane-7,9-dione hydrochloride |
C21H32ClN5O2 |
33386-08-2 |
|
| Irbesartan Bromo N2-Trityl Impurity
5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H- tetrazole |
C33H25BrN4 |
124750-51-2 |
|
| Olmesartan Impurity (N-(Triphenylmethyl)
1H-Tetrazole, 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-1-
(triphenylmethyl) |
C33H25BrN4 |
124750-51-2 |
|
| Losartan Bromo N1-Trityl Impurity |
C33H25BrN4 |
124750-51-2 |
|
| Candesartan Bromo N1-Trityl Impurity
5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-
tetrazole |
C33H25BrN4 |
124750-51-2 |
|
| Sitagliptin Impurity 19
(R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5- trifluorophenyl)butanoic acid |
C15H18F3NO4 |
486460-00-8 |
|
| Paracetamol EP Impurity I
1-(2-hydroxyphenyl)ethan-1-one |
C8H8O2 |
118-93-4 |
|
| Azithromycin |
C38H74N2O13 |
117772-70-0 |
|
| Aripiprazole Bromobutoxyquinoline Impurity
7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one |
C13H16BrNO2 |
129722-34-5 |
|
| Fenticonazole Nitrate
1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)-
1H-imidazole nitrate |
C24H21Cl2N3O4S |
73151-29-8 |
|
| Lansoprazole EP Impurity E
2-Mercaptobenzimidazole |
C7H6N2S |
583-39-1 |
|
| Rabeprazole EP Impurity F
Rabeprazole USP Related Compound C ; Lansoprazole EP Impurity E |
C7H6N2S |
583-39-1 |
|
| Gabapentin EP Impurity B
Gabapentin USP Related Compound B;(1- Cyanocyclohexyl)acetic acid |
C9H13NO2 |
133481-09-1 |
|
| Esomeprazole EP Impurity D
Esomeprazole USP Related Compound A ; Esomeprazole USP RC A ; Omeprazole Sulfone |
C17H19N3O4S |
88546-55-8 |
|
| Omeprazole EP Impurity D
Esomeprazole EP Impurity D ; Esomeprazole USP Related
Compound A |
C17H19N3O4S |
88546-55-8 |
|
| N1-Trityl Olmesartan Medoxomil
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-[1- (triphenylmethyl)-1H-tetrazol-5-yl][1,1’-biphenyl]-4-yl]methyl]- 1H-Imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-
yl)Methyl Ester |
C48H44N6O6 |
144690-92-6 |
|
| BROMO(2-FLUROPHENYL)ACETIC ACID |
C8H6BrFO2 |
134770-09-5 |
|
| Ivabradine Impurity 3
1-bromo-3-chloropropane |
C3H6BrCl |
109-70-6 |
|
| Alfuzosin HCl
(RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2- yl)(methyl)amino]propyl]tetrahydrofuran-2-carboxamide hydrochloride |
C19H28ClN5O4 |
81403-68-1 |
|
| N- nitrosodiethylamine (NDEA).
N-Ethyl-N-nitrosoethanamine; DEN; DENA; Diethylnitrosamide |
C4H10N2O |
55-18-5 |
|
| Desloratadine N-Methyl Impurity
Loratadine EP Impurity G ;Loratadine USP RC B |
C20H21ClN2 |
38092-89-6 |
|
| Loratadine EP Impurity G
N-Methyl Desloratadine ; Loratadine USP Related Compound B |
C20H21ClN2 |
38092-89-6 |
|
| Metronidazole EP impurity B
4-nitro-1H-imidazole |
C3H3N3O2 |
3034-38-6 |
|
| Ondansetron EP Impurity H
3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-
carbazol-4-one |
C17H17N3O |
99614-14-9 |
|
| Carbamazepine EP Impurity D
5H-Dibenzo[b,f]azepine |
C14H11N |
256-96-2 |
|
| Oxcarbazepine EP Impurity E
5H-dibenzo[b,f]azepine, Iminostilbene |
C14H11N |
256-96-2 |
|
| Mesalazine EP Impurity B
3-aminophenol, Mesalamine EP Impurity B |
C6H7NO |
591-27-5 |
|
| Piroxicam EP Impurity L
1-methylethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-
carboxylate 1,1-dioxide |
C13H15NO5S |
118854-48-1 |
|
| Meloxicam EP Impurity F
Meloxicam USP Related Compound C ;
isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3- carboxylate 1,1-dioxide |
C13H15NO5S |
118854-48-1 |
|
| Chlortalidone EP impurity B
Chlorthalidone USP RC A ; Chlorthalidone Acid ;
2-[3-(Aminosulfonyl)-4-chlorobenzoyl]-benzonic acid |
C14H10ClNO5S |
5270-74-6 |
|
| Mesalazine EP Impurity I
2-hydroxy-5-(phenyldiazenyl)benzoic acid (phenylazosalicylic acid).; Mesalamine EP Impurity I |
C13H10N2O3 |
3147-53-3 |
|
| (3Z)-4-Hydroxy-4-(6-methoxy-2-naphthalenyl)-3-buten- 2-one |
C15H14O3 |
218768-11-7 |
|
| Amlodipine EP impurity A
Amlodipine USP RC D,Phthaloyl Amlodipine |
C28H27ClN2O7 |
88150-62-3 |
|
| Montelukast EP Impurity C
Montelukast USP Related Compound A ; Montelukast Sulfoxide |
C35H36ClNO4S |
909849-96-3 |
|
| Rabeprazole EP Impurity A
Rabeprazole USP Related Compound D ; Rabeprazole Sulfone ; |
C18H21N3O4S |
117976-47-3 |
|
| Rivaroxaban
5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5- oxazolidinyl] methyl]-2-thiophenecarboxamide |
C19H18ClN3O5S |
366789-02-8 |
|
| Lidocaine
Anestacon ; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide |
C14H22N2O |
137-58-6 |
|
| Desloratadine N-Acetyl Impurity
Desloratadine N-Acetyl Impurity ; N-Acetyl Desloratadine |
C21H21ClN2O |
117796-52-8 |
|
| Paracetamol EP Impurity H
4-acetamidophenyl acetate |
C10H11NO3 |
2623-33-8 |
|
| Ethacrynic Acid impurity A
4-Butanoyl-2, 3-dichlorophenoxy acetic acid |
C12H12Cl2O4 |
1217-67-0 |
|
| Teriflunomide Impurity 18
2-cyano-N-(4-(trifluoromethyl)phenyl)acetamide |
C10H7F3N2O |
24522-30-3 |
|
